According to our (Global Info Research) latest study, the global Morphine Sulfate market size was valued at US$ 3396 million in 2025 and is forecast to a readjusted size of US$ 4268 million by 2032 with a CAGR of 3.3% during review period.
In 2025, global Morphine Sulfate output reached about 11 billion dosage units and global capacity of around 12 billion dosage units. The average price is about USD 0.30 per dosage unit, with gross margins near 45%. Morphine Sulfate is a pharmaceutical-grade opioid analgesic produced by converting morphine base into its sulfate salt to improve stability, solubility, and suitability for oral, injectable, and controlled-release dosage forms. It is one of the most widely used strong opioid medications for the management of moderate to severe acute and chronic pain, postoperative pain, cancer pain, trauma, myocardial infarction-related pain, and palliative or end-of-life care. Morphine sulfate acts primarily as a μ-opioid receptor agonist within the central nervous system, producing potent analgesic effects while also causing sedation, respiratory depression, and other opioid-related effects. The supply chain begins upstream with the cultivation of opium poppies (Papaver somniferum) under strict government regulation, extraction of opium alkaloids, purification of morphine base, production of pharmaceutical-grade morphine sulfate active pharmaceutical ingredient (API), and sourcing of pharmaceutical excipients, sterile solvents, packaging materials, and quality-control reagents. Midstream activities include API manufacturing, formulation into tablets, oral solutions, injections, sustained-release capsules, and extended-release tablets, followed by sterile filling, packaging, regulatory compliance, and distribution through licensed pharmaceutical wholesalers. Downstream, morphine sulfate is supplied to hospitals, surgical centers, oncology clinics, hospices, emergency medical services, retail and specialty pharmacies, long-term care facilities, military and disaster medicine organizations, and home healthcare providers, where its use is tightly regulated under national controlled-substance legislation to ensure secure handling, traceability, and appropriate clinical use.
This report is a detailed and comprehensive analysis for global Morphine Sulfate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Morphine Sulfate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Morphine Sulfate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Morphine Sulfate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Morphine Sulfate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Morphine Sulfate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Morphine Sulfate market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Nhwa Pharmaceutical, Humanwell Healthcare Group, Mallinckrodt Pharmaceuticals, Hikma Pharmaceuticals, Viatris, Pfizer, Fresenius Kabi, Hameln Pharma, Teva Pharmaceutical, Sun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Morphine Sulfate market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Immediate-Release (IR)
Controlled-Release (CR)
Sustained-Release (SR)
Market segment by Strength
<15 mg
15–30 mg
30–60 mg
60–100 mg
>100 mg
Market segment by Application
Acute Pain Management
Chronic Pain Management
Major players covered
Jiangsu Nhwa Pharmaceutical
Humanwell Healthcare Group
Mallinckrodt Pharmaceuticals
Hikma Pharmaceuticals
Viatris
Pfizer
Fresenius Kabi
Hameln Pharma
Teva Pharmaceutical
Sun Pharmaceutical
Amneal Pharmaceuticals
Rhodes Pharmaceuticals
Purdue Pharma
Sandoz
Alcaliber
Tasmanian Alkaloids
G.L. Pharma
Martindale Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Morphine Sulfate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Morphine Sulfate, with price, sales quantity, revenue, and global market share of Morphine Sulfate from 2021 to 2026.
Chapter 3, the Morphine Sulfate competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Morphine Sulfate breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Morphine Sulfate market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Morphine Sulfate.
Chapter 14 and 15, to describe Morphine Sulfate sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Morphine Sulfate. Industry analysis & Market Report on Morphine Sulfate is a syndicated market report, published as Global Morphine Sulfate Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Morphine Sulfate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.